Two roads for oncolytic immunotherapy development
| Title: | Two roads for oncolytic immunotherapy development |
|---|---|
| Authors: | Howard L. Kaufman, Praveen K. Bommareddy |
| Source: | Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-5 (2019) |
| Publisher Information: | BMJ Publishing Group, 2019. |
| Publication Year: | 2019 |
| Collection: | LCC:Neoplasms. Tumors. Oncology. Including cancer and carcinogens |
| Subject Terms: | Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282 |
| More Details: | Abstract Oncolytic viruses are an emerging class of immunotherapy agents for cancer treatment. In this issue of JITC, Machiels et al. reports early phase data from an oncolytic adenovirus given by intravenous (IV) administration. While this may allow easy access to metastatic lesions, there is limited data supporting the therapeutic effectiveness of this approach. Further studies should include assessment of viral replication in tumor tissue and consider comparative trials using IV and intratumoral delivery to fully optimize oncolytic immunotherapy. |
| Document Type: | article |
| File Description: | electronic resource |
| Language: | English |
| ISSN: | 2051-1426 |
| Relation: | http://link.springer.com/article/10.1186/s40425-019-0515-2; https://doaj.org/toc/2051-1426 |
| DOI: | 10.1186/s40425-019-0515-2 |
| Access URL: | https://doaj.org/article/639dae61c57c458287a00f4d26a00b8f |
| Accession Number: | edsdoj.639dae61c57c458287a00f4d26a00b8f |
| Database: | Directory of Open Access Journals |
| FullText | Text: Availability: 0 CustomLinks: – Url: https://resolver.ebsco.com/c/xy5jbn/result?sid=EBSCO:edsdoj&genre=article&issn=20511426&ISBN=&volume=7&issue=1&date=20190201&spage=1&pages=1-5&title=Journal for ImmunoTherapy of Cancer&atitle=Two%20roads%20for%20oncolytic%20immunotherapy%20development&aulast=Howard%20L.%20Kaufman&id=DOI:10.1186/s40425-019-0515-2 Name: Full Text Finder (for New FTF UI) (s8985755) Category: fullText Text: Find It @ SCU Libraries MouseOverText: Find It @ SCU Libraries – Url: https://doaj.org/article/639dae61c57c458287a00f4d26a00b8f Name: EDS - DOAJ (s8985755) Category: fullText Text: View record from DOAJ MouseOverText: View record from DOAJ |
|---|---|
| Header | DbId: edsdoj DbLabel: Directory of Open Access Journals An: edsdoj.639dae61c57c458287a00f4d26a00b8f RelevancyScore: 918 AccessLevel: 3 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 917.677612304688 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Two roads for oncolytic immunotherapy development – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Howard+L%2E+Kaufman%22">Howard L. Kaufman</searchLink><br /><searchLink fieldCode="AR" term="%22Praveen+K%2E+Bommareddy%22">Praveen K. Bommareddy</searchLink> – Name: TitleSource Label: Source Group: Src Data: Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-5 (2019) – Name: Publisher Label: Publisher Information Group: PubInfo Data: BMJ Publishing Group, 2019. – Name: DatePubCY Label: Publication Year Group: Date Data: 2019 – Name: Subset Label: Collection Group: HoldingsInfo Data: LCC:Neoplasms. Tumors. Oncology. Including cancer and carcinogens – Name: Subject Label: Subject Terms Group: Su Data: <searchLink fieldCode="DE" term="%22Neoplasms%2E+Tumors%2E+Oncology%2E+Including+cancer+and+carcinogens%22">Neoplasms. Tumors. Oncology. Including cancer and carcinogens</searchLink><br /><searchLink fieldCode="DE" term="%22RC254-282%22">RC254-282</searchLink> – Name: Abstract Label: Description Group: Ab Data: Abstract Oncolytic viruses are an emerging class of immunotherapy agents for cancer treatment. In this issue of JITC, Machiels et al. reports early phase data from an oncolytic adenovirus given by intravenous (IV) administration. While this may allow easy access to metastatic lesions, there is limited data supporting the therapeutic effectiveness of this approach. Further studies should include assessment of viral replication in tumor tissue and consider comparative trials using IV and intratumoral delivery to fully optimize oncolytic immunotherapy. – Name: TypeDocument Label: Document Type Group: TypDoc Data: article – Name: Format Label: File Description Group: SrcInfo Data: electronic resource – Name: Language Label: Language Group: Lang Data: English – Name: ISSN Label: ISSN Group: ISSN Data: 2051-1426 – Name: NoteTitleSource Label: Relation Group: SrcInfo Data: http://link.springer.com/article/10.1186/s40425-019-0515-2; https://doaj.org/toc/2051-1426 – Name: DOI Label: DOI Group: ID Data: 10.1186/s40425-019-0515-2 – Name: URL Label: Access URL Group: URL Data: <link linkTarget="URL" linkTerm="https://doaj.org/article/639dae61c57c458287a00f4d26a00b8f" linkWindow="_blank">https://doaj.org/article/639dae61c57c458287a00f4d26a00b8f</link> – Name: AN Label: Accession Number Group: ID Data: edsdoj.639dae61c57c458287a00f4d26a00b8f |
| PLink | https://login.libproxy.scu.edu/login?url=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsdoj&AN=edsdoj.639dae61c57c458287a00f4d26a00b8f |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1186/s40425-019-0515-2 Languages: – Text: English PhysicalDescription: Pagination: PageCount: 5 StartPage: 1 Subjects: – SubjectFull: Neoplasms. Tumors. Oncology. Including cancer and carcinogens Type: general – SubjectFull: RC254-282 Type: general Titles: – TitleFull: Two roads for oncolytic immunotherapy development Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Howard L. Kaufman – PersonEntity: Name: NameFull: Praveen K. Bommareddy IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 02 Type: published Y: 2019 Identifiers: – Type: issn-print Value: 20511426 Numbering: – Type: volume Value: 7 – Type: issue Value: 1 Titles: – TitleFull: Journal for ImmunoTherapy of Cancer Type: main |
| ResultId | 1 |